| Amanda Alberti-correa, | |
|
13400 E Shea Blvd, Scottsdale, AZ 85259-5452 | |
| (480) 301-8000 | |
| Not Available |
| Full Name | Amanda Alberti-correa |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 13400 E Shea Blvd, Scottsdale, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780349043 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTH-008620 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Alberti-correa, 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 | Amanda Alberti-correa, 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 |
News Archive
For some women, planning a family can be the first step towards one of life's most rewarding experiences. But a study led by Ryerson University researchers has found strong evidence that some HIV-positive women feel that they are being judged negatively by their healthcare providers for wanting to become moms and feel stigmatized by their physicians due to their medical condition.
The Human Molecular Genetics laboratory of the de Duve Institute (UCLouvain), headed by Professor Miikka Vikkula, recently identified mutations in a novel gene, ANGPT2, responsible for primary lymphedema.
In his second annual letter, Bill Gates reflects on the Bill & Melinda Gates Foundation's work and the importance innovation will play in overcoming some of the world's greatest challenges, including in global health and agriculture, the Associated Press reports. "Gates says the foundation currently is backing 30 areas of innovation including online learning, teacher improvement, malaria vaccine development, HIV prevention, and genetically modified seeds," according to the news service (Gordon Blankinship, 1/25).
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
› Verified 6 days ago
Ms. Attria Batoon Honda, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12000 N 90th T., Scottsdale, AZ 85260 Phone: 480-451-2033 | |
Jennifer Klaine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1475 N Granite Reef Rd, Scottsdale, AZ 85257 Phone: 480-990-1904 | |
Jared Stuck, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 16413 N 91st St Bldg C145, Scottsdale, AZ 85260 Phone: 480-447-3262 Fax: 480-630-2066 | |
Emily Ludwig, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 13802 N Scottsdale Rd Ste 163, Scottsdale, AZ 85254 Phone: 480-401-1848 | |
Siyu Yi, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 7025 N Scottsdale Rd Ste 200, Scottsdale, AZ 85253 Phone: 602-385-8733 | |
Ms. Connie Sue Williams, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8115 E Indian Bend Rd, Ste 123, Scottsdale, AZ 85250 Phone: 480-951-6451 | |
Tonya Lee Soules, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8429 E Via De Jardin, Scottsdale, AZ 85258 Phone: 480-664-1266 |